The IRF9 gene helps your cells respond to interferons, the chemical signals your body uses to switch on antiviral defenses. If this gene does not work properly, your body may struggle to control some viral infections, and some people develop unusually severe illness. Pathogenic variants in the IRF9 gene are linked to a rare inherited immune condition with increased susceptibility to viruses, especially certain respiratory viruses. IRF9 is mainly known in medical and research settings rather than popular culture.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or direct processes in the body. Some genes provide the directions for making proteins, the parts of cells that do much of the work. Others mainly regulate when certain processes happen, where they happen, and how strongly they are carried out. As a group, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medications. To explore this subject in greater depth, you can read more in the LearnHub.
Overview
IRF9Gene function
What if the gene works
The IRF9 gene helps your cells respond to interferons, which are immune warning signals. It works with other proteins to switch on genes that support antiviral defense and help control infections.
Risk
What if the gene does not work
Variants in the IRF9 gene can weaken the body's interferon response, which helps control viruses. More disruptive variants are linked to a rare immune condition with recurrent or severe viral infections, including influenza, while milder variants may have less effect.
Treatment
What does that mean for your treatment
No treatment or management approach specific to the IRF9 gene is currently established. In research, the IRF9 gene is being studied as part of interferon signaling and as a possible biomarker of response to some antiviral and cancer treatments.
Gene function
What if the gene works
When viruses enter the body, your cells need a fast way to switch on antiviral defenses. The IRF9 gene helps control that response after interferon signals arrive, acting as part of the cell’s early immune alarm system. This is central to IRF9 gene function in the immune system.
The IRF9 gene helps cells respond to interferon signals, which are immune alarm messages released during infections. It teams up with partner proteins called STAT1 and STAT2 so that this message can reach the cell’s control center.
Inside the control center, IRF9 helps the cell switch on interferon-stimulated genes (genes that help cells react to infection). These genes prepare the cell for a more organized immune response.
By turning on these protective genes, the IRF9 gene supports the production of proteins that make it harder for viruses to copy themselves and spread. This helps cells enter a more protected state.
What is a variant?
A genetic variant is a slight change in the DNA sequence within a gene. These changes are common and help account for normal human diversity, such as differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not cause any noticeable effect and simply represent natural genetic variation. In some cases, though, a variant can change how a gene works more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
IRF9 gene variants can reduce how strongly cells respond to interferon signals, which helps explain how IRF9 gene variants affect interferon signaling. Some variants lower the amount of IRF9 protein, while others make the protein unstable or weaken its ability to join partner proteins and turn on antiviral genes. Milder variants may leave some activity, but more severe variants can cause little or no function. In people with disease-causing variants, this often lines up with earlier or more marked viral illness.
How variants are linked to conditions
Pathogenic variants in the IRF9 gene can cause IRF9 deficiency, a rare inherited immune condition. In studies and case reports, variants in the IRF9 gene linked to severe viral infections have been associated most clearly with influenza, and some people have also developed severe COVID-19 or other respiratory viral illnesses. Because this is a single-gene condition, finding disease-causing variants in both copies of the IRF9 gene can confirm the diagnosis.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are common throughout the general population. Most do not have a direct effect on health and simply contribute to natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when multiple genes and environmental factors play a role. In some situations, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the IRF9 gene. For people with a disease-causing IRF9 change, risk is more closely linked to the variant itself and exposure to certain viral infections than to lifestyle factors, so regular medical follow-up can help guide prevention and early care.
Inheritance of IRF9 variants
IRF9-related disease is inherited in an autosomal recessive pattern. In practical terms, how IRF9 gene variants are inherited usually means a person needs to receive one altered copy of the IRF9 gene from each parent to have the condition. Parents who each carry one IRF9 variant are often healthy themselves, and with each pregnancy they have a 25% chance of having an affected child, a 50% chance of having a child who is a carrier, and a 25% chance of having a child who inherits neither variant. Because the IRF9 gene is on chromosome 14, this pattern affects males and females similarly.
What does my IRF9 result mean for my family?
For IRF9, the main family impact is usually for relatives in the same branch of the family, because the related immune condition is typically passed down in a recessive way. Brothers and sisters may also be affected or may carry the same gene change without symptoms, and parents are often healthy carriers. Children of someone with an IRF9-related condition usually inherit one changed copy, and the chance of an affected child depends on whether the other parent also carries an IRF9 change.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for variants in the IRF9 gene usually uses a blood or saliva sample, and a lab reads the gene’s DNA sequence to look for changes. Results may identify a benign variant, a variant linked to an IRF9 related condition, or an uncertain finding that needs clinical interpretation.
When should I consider getting a genetic test?
Consider testing for changes in the IRF9 gene if someone has had repeated or unusually severe viral infections, especially serious flu or pneumonia starting in childhood, or if there is a family history of the same pattern. Testing can help explain the cause and guide care for relatives.
A genetic result is only one part of your health story
Genetic findings can be informative, yet how much they clarify varies with the condition and the kind of variant present. Over time, many factors shape how the body functions, including lifestyle, environment, age, and medical history. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is most useful when considered alongside other parts of care. In other situations, a genetic result can give a clear answer. In areas like medication response, genetic results may also help put personal experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in genes can change how the body breaks down a drug, moves it through the body, or reacts to it at its target. This helps explain why the same treatment works well for one person, works less well for another, or causes more side effects in some people.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can affect a person’s response to medication. It looks at connections between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes influence how strongly a drug works or how the body handles it. This information can support treatment decisions that are better informed and more individualized. To explore this topic further, you can learn more in the LearnHub.
Drugs influenced by the IRF9 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding everyday medication choices, so questions about side effects, drug response, or new symptoms are best discussed with your doctor. IRF9 has been studied because it helps the body respond to immune-signaling medicines called interferons, but this is not part of routine prescribing.
History
IRF9 entered the scientific literature through interferon research in the late 1980s and early 1990s, when scientists were trying to understand how cells respond to viral infection. Initially understood only through its role in a protein group called ISGF3, it was first known as p48 or ISGF3γ before being linked clearly to the IRF family. From these first observations, research expanded steadily. As medical science evolved, researchers showed that the IRF9 gene was a central part of the body’s interferon signaling pathway, which helped connect earlier lab findings into a clearer picture. Over time, descriptions became more precise, and rare inherited variants in the IRF9 gene were later recognized in people with unusual vulnerability to certain infections. These historical steps shaped today’s understanding.